ONCOLYTICS BIOTECH INC. (ONCY) Financial Statements

ONCOLYTICS BIOTECH INC. (ONCY) files with the U.S. Securities and Exchange Commission under CIK 0001129928. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2025

Net Cash from Operations: -20.11 million CAD

Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Aug 12, 2026. Source: SEC filings (EDGAR XBRL). Amounts in CAD.

Open the full financial statements for ONCY in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History